Menu

Life Sciences

Innovative Solutions for Business Leaders

In today’s complicated regulatory environment, it is more important than ever for life sciences companies to align themselves with financial professionals experienced in all aspects of the industry. We know the growing number of complex challenges your business faces - from development, to becoming a commercial organization and capitalizing on tax-efficient strategies and leveraging intellectual property. Our Life Sciences team can help guide you every step of the way.

Recommended insight

INSIGHT ARTICLE

Improvements to employee share-based payment accounting

Learn about improvements to the share-based compensation standard and its impact on the life sciences industry.

CASE STUDY

RSM helps emerging life sciences company increase financial visibility

RSM worked with InteguRX to develop a comprehensive FAO solution for more financial visibility and consistency that will scale with growth.

INSIGHT ARTICLE

The benefits of finance and accounting outsourcing for life sciences

Learn how growing life sciences companies leverage finance and accounting outsourcing to enhance the finance function and focus on core competencies.

WHITE PAPER

Project accounting: Utilizing ERP to effectively track costs and resources

Project-based companies must understand how to choose the right ERP system to increase visibility and monitor project health and available resources.

WHITE PAPER

Beyond QuickBooks: Choosing the right ERP solution for your organization

Enterprise resource planning (ERP) is the next step for companies that need a more comprehensive platform than QuickBooks. Learn when to consider an ERP system, as well as insights into the system selection and implementation process.

WHITE PAPER

Finance transformation in the pharmaceutical industry

Commercializing new drugs is more challenging than ever, but increasing focus on your finance function can better manage a difficult business model.

Review recovers millions in royalties for life sciences company

CASE STUDY

Review recovers millions in royalties for life sciences company

Royalty review of three licensees discovers omitted products, unallowable deductions, unreported sales and nearly $4.5 million in underpaid royalties.

CASE STUDY

RSM helps biopharmaceutical company save IPO price

With IPO on the line, RSM delivers valuation client needs to finance the future.

CASE STUDY

Osmotica Pharmaceutical

Michael Gesser, Vice President of Finance and Treasurer of Osmotica Pharmaceutical, discuss how their implementation of Microsoft Dynamics AX has positioned their business for future growth

Contact Our Team

John Lanza
Partner,
National Practice Leader

800.274.3978
John.Lanza@rsmus.com